from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2328/PE23

LFCtreatmentdescriptionclass of inhibitor

-0.345

Amikacinug/mL Amikacintranslation

1.194

Cap5-10ug/mL Capreomycintranslation

1.105

Rox10-50 ug/mL Roxithromycintranslation

0.698

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.499

Rif0.2-5ug/mL Rifampicintranscription

0.851

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.741

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.866

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.133

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.433

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.015

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.061

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.126

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.115

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.824

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.338

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.205

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.141

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.877

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.452

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.068

Nigericin50 uM Nigericinrespiration

0.607

TRC10-150 ug/mL Triclosanrespiration

-0.862

TRZ10-25 ug/mL Thioridazinerespiration

0.242

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.389

menadione6-10 ug/mL Menadionerespiration

0.027

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.213

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.154

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.147

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.075

NRP_1Non-replicating persistence stage 1dosRassociated

-0.590

Amp0.2mg/mL AmpicillincellWall

-0.295

Cephalexin20-100 ug/mL CephalexincellWall

0.975

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.915

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.633

EMB10-20 ug/mL EthambutolcellWall

0.477

Eta12-40 ug/mL EthionamidecellWall

0.123

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.553

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.076

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.418

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.712

BZA0.12 mg/mL BenzamidearomaticAmides

-0.284

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.120

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.235

H2O24 mM hydrogen peroxideDNAdamaging

0.065

Levo10 ug/mL LevofloxacinDNAdamaging

-0.438

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.233

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.456

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.416

UVUV-irradiationDNAdamaging

1.129

ARP41-4 ug/mL Antitubercular compound ARP4?

0.068

Antimycin12.5-50 ug/mL Antimycin A?

-0.328

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.334

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.424

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.359

PA8240.2-2 ug/mL PA-824?

1.169

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.417

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.460

Verapamil50 uM Verapamil?

-0.307

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.760

methoxatin10-20 ug/mL Methoxatin?